SU591147A3 - Способ получени 5,9- дизамещенных 2-тетрагидрофурфурил-6,7-бензоморфанов или их солей - Google Patents

Способ получени 5,9- дизамещенных 2-тетрагидрофурфурил-6,7-бензоморфанов или их солей

Info

Publication number
SU591147A3
SU591147A3 SU752162235A SU2162235A SU591147A3 SU 591147 A3 SU591147 A3 SU 591147A3 SU 752162235 A SU752162235 A SU 752162235A SU 2162235 A SU2162235 A SU 2162235A SU 591147 A3 SU591147 A3 SU 591147A3
Authority
SU
USSR - Soviet Union
Prior art keywords
tetrahydrofurfuryl
dimethyl
mol
hydroxy
methanol
Prior art date
Application number
SU752162235A
Other languages
English (en)
Russian (ru)
Inventor
Мерц Герберт
Лангбейн Адольф
Вальтер Герхард
Штокхаус Клаус
Original Assignee
К.Х Берингер Зон (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by К.Х Берингер Зон (Фирма) filed Critical К.Х Берингер Зон (Фирма)
Application granted granted Critical
Publication of SU591147A3 publication Critical patent/SU591147A3/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SU752162235A 1974-08-05 1975-07-25 Способ получени 5,9- дизамещенных 2-тетрагидрофурфурил-6,7-бензоморфанов или их солей SU591147A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2437610A DE2437610A1 (de) 1974-08-05 1974-08-05 Neue 5,9-beta-disubstituierte 2-tetrahydrofurfuryl-6,7-benzomorphane, deren saeureadditionssalze, ihre verwendung als arzneimittel und verfahren zu deren herstellung

Publications (1)

Publication Number Publication Date
SU591147A3 true SU591147A3 (ru) 1978-01-30

Family

ID=5922448

Family Applications (3)

Application Number Title Priority Date Filing Date
SU752162235A SU591147A3 (ru) 1974-08-05 1975-07-25 Способ получени 5,9- дизамещенных 2-тетрагидрофурфурил-6,7-бензоморфанов или их солей
SU762346108A SU587859A3 (ru) 1974-08-05 1976-04-16 Способ получени 5,9 -дизамещенных 2-тетрагидрофурфурил-6,7-бензоморфанов или их солей
SU762346107A SU587858A3 (ru) 1974-08-05 1976-04-16 Способ получени 5,9- -дизамещенных-2-тетрагидрофурфурил-6,7бензоморфанов или их солей

Family Applications After (2)

Application Number Title Priority Date Filing Date
SU762346108A SU587859A3 (ru) 1974-08-05 1976-04-16 Способ получени 5,9 -дизамещенных 2-тетрагидрофурфурил-6,7-бензоморфанов или их солей
SU762346107A SU587858A3 (ru) 1974-08-05 1976-04-16 Способ получени 5,9- -дизамещенных-2-тетрагидрофурфурил-6,7бензоморфанов или их солей

Country Status (27)

Country Link
US (1) US3982005A (enExample)
JP (1) JPS60358B2 (enExample)
AT (1) AT348140B (enExample)
BE (1) BE832099R (enExample)
BG (3) BG25090A3 (enExample)
CA (1) CA1049008A (enExample)
CH (7) CH613963A5 (enExample)
CS (1) CS189717B2 (enExample)
DD (1) DD122685A5 (enExample)
DE (1) DE2437610A1 (enExample)
DK (1) DK138992C (enExample)
ES (6) ES452765A1 (enExample)
FI (1) FI63229C (enExample)
FR (1) FR2320096A2 (enExample)
GB (1) GB1513950A (enExample)
HU (1) HU177952B (enExample)
IE (1) IE42216B1 (enExample)
IL (1) IL47860A (enExample)
LU (1) LU73138A1 (enExample)
NL (1) NL7509249A (enExample)
NO (1) NO143460C (enExample)
PH (1) PH13687A (enExample)
PL (3) PL99819B1 (enExample)
RO (3) RO67390A (enExample)
SE (1) SE425392B (enExample)
SU (3) SU591147A3 (enExample)
ZA (1) ZA754997B (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087532A (en) * 1974-03-09 1978-05-02 Boehringer Ingelheim Gmbh Analgesically useful 2-tetrahydrofurfuryl-5-lower alkyl-2-oxy-6,7-benzomorphans and salts thereof
GB1575009A (en) * 1976-06-21 1980-09-17 Acf Chemiefarma Nv 6,7-benzomorphan derivatives
DE2716687A1 (de) * 1977-04-15 1978-10-19 Boehringer Sohn Ingelheim 2'-hydroxy-2-(5-isoxazolylmethyl)-6,7benzomorphane, deren saeureadditionssalze und diese enthaltende arzneimittel
NL7804509A (nl) * 1978-04-26 1979-10-30 Acf Chemiefarma Nv Nieuwe 6,7-benzomorfanderivaten en zuuradditiezouten daarvan.
DE2828039A1 (de) * 1978-06-26 1980-01-10 Boehringer Sohn Ingelheim 2-(2-alkoxyethyl)-2'-hydroxy-6,7-benzomorphane deren saeureadditionssalze diese enthaltende arzneimittel und verfahren zu deren herstellung
JPS5636521A (en) * 1979-08-31 1981-04-09 Shin Etsu Chem Co Ltd Production of alkenyloxy group-containing organopolysiloxane
JP5451611B2 (ja) 2007-07-26 2014-03-26 ヴァイティー ファーマシューティカルズ，インコーポレイテッド １１β−ヒドロキシステロイドデヒドロゲナーゼ１のサイクリックインヒビター
US8859580B2 (en) 2007-11-16 2014-10-14 Boehringer Ingelheim International Gmbh Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
CA2708303A1 (en) 2007-12-11 2009-06-18 Vitae Pharmaceuticals, Inc. Cyclic urea inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1
TW200934490A (en) 2008-01-07 2009-08-16 Vitae Pharmaceuticals Inc Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
WO2009094169A1 (en) 2008-01-24 2009-07-30 Vitae Pharmaceuticals, Inc. Cyclic carbazate and semicarbazide inhibitors of 11beta-hydroxysteroid dehydrogenase 1
US8598160B2 (en) 2008-02-15 2013-12-03 Vitae Pharmaceuticals, Inc. Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
TW201004945A (en) 2008-05-01 2010-02-01 Vitae Pharmaceuticals Inc Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
KR20110002492A (ko) 2008-05-01 2011-01-07 비타이 파마슈티컬즈, 인코포레이티드 11베타-하이드록시스테로이드 탈수소효소 1의 고리형 억제제
EP2291370B1 (en) 2008-05-01 2013-11-27 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
US8765780B2 (en) 2008-05-13 2014-07-01 Boehringer Ingelheim International Gmbh Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use
WO2010011314A1 (en) 2008-07-25 2010-01-28 Boehringer Ingelheim International Gmbh Cyclic inhibitors of 11 beta-hydroxysteroid dehydrogenase 1
US8846668B2 (en) 2008-07-25 2014-09-30 Vitae Pharmaceuticals, Inc. Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
UA109255C2 (ru) 2009-04-30 2015-08-10 Берінгер Інгельхайм Інтернешнл Гмбх Циклические ингибиторы 11бета-гидроксистероиддегидрогеназы 1
WO2011011123A1 (en) 2009-06-11 2011-01-27 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure
AR078887A1 (es) 2009-11-06 2011-12-07 Boehringer Ingelheim Int Derivados arilo y heteroarilcarbonilo de hexahidroindenopiridina y octahidrobenzoquinolina y composiciones farmaceuticas que los contienen.
EP2582698B1 (en) 2010-06-16 2016-09-14 Vitae Pharmaceuticals, Inc. Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
TWI537258B (zh) 2010-11-05 2016-06-11 百靈佳殷格翰國際股份有限公司 六氫茚并吡啶及八氫苯并喹啉之芳基－及雜環芳基羰基衍生物
US8735585B2 (en) 2011-08-17 2014-05-27 Boehringer Ingelheim International Gmbh Indenopyridine derivatives
KR20230112134A (ko) 2020-11-26 2023-07-26 신에쓰 가가꾸 고교 가부시끼가이샤 실온경화성 오르가노폴리실록산 조성물 및 물품 그리고 가수분해성 오르가노실란 화합물 및 그 제조 방법
EP4397695A4 (en) 2021-09-03 2025-09-10 Shinetsu Chemical Co ORGANOPOLYSILOXANE COMPOUND, ROOM TEMPERATURE CURABLE ORGANOPOLYSILOXANE COMPOSITION AND ARTICLE

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE582575A (enExample) * 1958-09-22
US3700734A (en) * 1969-01-23 1972-10-24 Merck & Co Inc 2{40 -hydroxy-2,3,5-trimethyl-6,7-benzomorphan
DE2105743C3 (de) * 1971-02-08 1979-11-29 Boehringer Sohn Ingelheim 2-(Furylmethyl)- a -5,9-dialkyl -6,7benzomorphane, Verfahren zu ihrer Herstellung und deren Verwendung
CS166803B2 (enExample) * 1971-02-08 1976-03-29 Boehringer Sohn Ingelheim
DE2200596A1 (de) * 1972-01-07 1973-07-12 Boehringer Sohn Ingelheim N-(furyl-methyl)-2'-hydroxy-5-phenyl6,7-benzomorphane, deren saeureadditionssalze sowie verfahren zu deren herstellung
DE2217420C3 (de) * 1972-04-12 1981-03-12 C.H. Boehringer Sohn, 6507 Ingelheim N-Thienylmethyl-Heterocyclen, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zubereitungen
DE2229695A1 (de) * 1972-06-19 1974-01-31 Boehringer Sohn Ingelheim 2-(heteroaryl-methyl)-5,9 beta-dialkyl6,7-benzomorphane, deren saeureadditionssalze sowie verfahren zu deren herstellung

Also Published As

Publication number Publication date
IE42216B1 (en) 1980-07-02
HU177952B (en) 1982-02-28
CA1049008A (en) 1979-02-20
IL47860A0 (en) 1975-11-25
SU587858A3 (ru) 1978-01-05
ZA754997B (en) 1977-04-27
BG25088A3 (bg) 1978-07-12
BG25090A3 (bg) 1978-07-12
FR2320096B2 (enExample) 1978-09-01
NL7509249A (nl) 1976-02-09
CH615679A5 (enExample) 1980-02-15
PH13687A (en) 1980-09-01
RO67390A (ro) 1981-06-30
IE42216L (en) 1976-02-05
ES452765A1 (es) 1977-10-16
GB1513950A (en) 1978-06-14
CH616421A5 (enExample) 1980-03-31
DK352875A (da) 1976-02-06
NO143460B (no) 1980-11-10
NO752731L (enExample) 1976-02-06
DE2437610A1 (de) 1976-02-26
FI63229C (fi) 1983-05-10
AU8364675A (en) 1977-02-10
SE425392B (sv) 1982-09-27
CH616420A5 (enExample) 1980-03-31
ES452764A1 (es) 1977-10-16
ES452767A1 (es) 1977-10-01
PL99819B1 (pl) 1978-08-31
FI752211A7 (enExample) 1976-02-06
NO143460C (no) 1981-02-18
PL99838B1 (pl) 1978-08-31
ES452766A1 (es) 1977-10-01
LU73138A1 (enExample) 1977-04-13
RO72735A (ro) 1982-09-09
PL99816B1 (pl) 1978-08-31
ATA523775A (de) 1978-06-15
JPS5139673A (en) 1976-04-02
CH615678A5 (enExample) 1980-02-15
DD122685A5 (enExample) 1976-10-20
DK138992C (da) 1979-04-30
RO72736A (ro) 1982-09-09
ES452768A1 (es) 1977-10-01
CH615680A5 (enExample) 1980-02-15
JPS60358B2 (ja) 1985-01-07
AT348140B (de) 1979-01-25
BE832099R (fr) 1976-02-04
IL47860A (en) 1979-01-31
SU587859A3 (ru) 1978-01-05
US3982005A (en) 1976-09-21
BG25089A3 (bg) 1978-07-12
FI63229B (fi) 1983-01-31
SE7508789L (sv) 1976-02-10
DK138992B (da) 1978-11-27
CH615677A5 (enExample) 1980-02-15
CH613963A5 (enExample) 1979-10-31
ES452763A1 (es) 1977-10-01
CS189717B2 (en) 1979-04-30
FR2320096A2 (fr) 1977-03-04

Similar Documents

Publication Publication Date Title
US5037844A (en) Substituted 1H-indazole-3-carboxamides
FI82689C (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefull 2-etoxi-4-/n-(1-(2-piperidino-fenyl)-3-metyl -1-butyl)-aminokarbonylmetyl/-benzoesyras b- och c-form.
US4155909A (en) 2-Alkyl nicotinoids and processes for their production
US4080337A (en) Multioxymacrocycle compounds containing pyridyl rings as part of the macrocycle
US4076820A (en) Benzoquinolizines and hypotensive compositions containing them
KR870001159B1 (ko) 피라졸-환 알킬화된 피라졸로 퀴놀린의 제조방법
SU1042617A3 (ru) Способ получени производных нортропанола или их солей
JPS60358B2 (ja) ベンゾモルフアン化合物の製法
US4025513A (en) Synthesis for the preparation of tetracyclic compounds
CA1183836A (en) Dihydrobenzofuranyl derivatives of ala-pro
EP0206090A2 (en) Peptide renin inhibitors
Brine et al. An improved resolution of (±)‐cis‐N‐normetazocine
SU612631A3 (ru) Способ получени -(тетрагидрофурфурил)нороксиморфонов или их солей
CA2137611A1 (en) Epi-epibatidine derivatives
KR880001320B1 (ko) 2-시클릭아미노-2-(1, 2-벤지속사졸-3-일)아세트산 에스테르 유도체들의 제조방법
SU439982A1 (ru) Способ получени производных эрголена или эрголина
FI88292B (fi) Foerfarande foer framstaellning av n-(sulfonylmetyl)formamider
Portoghese et al. Synthesis, x-ray crystallographic determination, and opioid activity of erythro-5-methylmethadone enantiomers. Evidence which suggests that. mu. and. delta. opioid receptors possess different stereochemical requirements
US5756748A (en) Process for the preparation of sameridine
JPS595595B2 (ja) １５−ヒドロキシイミノ−ｅ−ホモエブルナン誘導体の製造方法
DE2742433A1 (de) 5,6-dihydro-imidazo eckige klammer auf 5,1-a eckige klammer zu isochinoline, ihre verwendung und herstellung
CN113816994B (zh) (1,1-二氰基-4-氧)-己基-3-氧化吲哚亚膦酸二乙酯及其衍生物的合成方法
SU922108A1 (ru) Способ получени производных 6-метил-8 @ -гидразинометилэрголина или их солей
US4647666A (en) Heterocyclic synthesis via thallation and subsequent palladium-promoted olefination
SU1038341A1 (ru) Способ получени @ -арилиндолотриметинцианинов